Exane Derivatives’s iShares Low Carbon Optimized MSCI ACWI ETF CRBN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.11M Sell
8,138
-1,675
-17% -$249K 0.64% 36
2022
Q1
$1.6M Sell
9,813
-327
-3% -$53.4K 0.45% 44
2021
Q4
$1.76M Buy
10,140
+968
+11% +$166K 0.43% 44
2021
Q3
$1.51M Buy
9,172
+4,649
+103% +$784K 0.36% 59
2021
Q2
$759K Buy
4,523
+3,688
+442% +$603K 0.17% 111
2021
Q1
$130K Buy
+835
New +$129K 0.04% 372

Other funds holding CRBN

Exane Derivatives's CRBN Position: Q2 2022 in Review

Exane Derivatives reduced its iShares Low Carbon Optimized MSCI ACWI ETF (CRBN) stake by 17% in Q2 2022, selling an estimated $249K and leaving 8,138 shares worth $1.11M. The position accounts for 0.64% of the portfolio, ranked #36.

Exane Derivatives first reported a position in CRBN in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.76M in Q4 2021. 121 funds tracked by Wall St. Rank hold CRBN as of Q2 2022.

  • Exane Derivatives held 8,138 shares of iShares Low Carbon Optimized MSCI ACWI ETF worth $1.11M as of Q2 2022.
  • Exane Derivatives sold 1,675 iShares Low Carbon Optimized MSCI ACWI ETF shares in Q2 2022, an estimated $249K.
  • iShares Low Carbon Optimized MSCI ACWI ETF made up 0.64% of Exane Derivatives's portfolio in Q2 2022, its #36 holding.
  • Exane Derivatives first reported a position in iShares Low Carbon Optimized MSCI ACWI ETF in Q1 2021 and has held it in 6 quarters since.
  • Exane Derivatives's iShares Low Carbon Optimized MSCI ACWI ETF position peaked at $1.76M in Q4 2021.
  • 121 funds tracked by Wall St. Rank held iShares Low Carbon Optimized MSCI ACWI ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.